Effect of Nebulized Bronchodilators on Heart Rate

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fahim Khorfan, MD
• Collaborators: Ascension Genesys Hospital; Genesys Regional Medical Center
• Treatments: Albuterol; Bronchodilator Agents; Ipratropium

Criteria

Inclusion Criteria:

• Adults who required inhaled bronchodilator therapy in the form of short acting beta adrenergic receptor agonist and short acting anti-cholinergic treatment every 4-6 hours for respiratory functions

Exclusion Criteria:

• Known allergy or sensitivity to study medications

• Baseline heart rate was greater than 110 beats per minute